drugset / Trial / NCT01793818
Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein
RandomizedParallel-groupDouble-blindTreatment
Summary
Tat Oyi vaccination on seropositive patients could help their immune system to recognize and neutralize Tat. The neutralization of extra cellular Tat should help the cellular immune response to eliminate HIV-1 infected cells.
Timeline
- Start
- 2013-02
- Primary completion
- 2016-03
- Completion
- 2016-03
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tat Oyi | Vaccine | 11 ug | Other |
| Comparator | Tat Oyi | Vaccine | 33 ug | Other |
| Comparator | Tat Oyi | Vaccine | 99 ug | Other |